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Abstrak
Latar Belakang: Setelah sekian tahun bergantung pada sumber pendaaan luar negeri, pembiayaan Program HIV AIDS 
di Indonesia  diharapkan  menggunakan sumber pendanaan dalam negeri. Skema Jaminan Kesehatan Semesta atau 
Jaminan Kesehatan Nasional (JKN) yang dimulai  tahun 2014 menanggung pengobatan  termasuk infeksi oportunistik. 
Pertanyaan penelitian apakah paket manfaatnya dapat mencakup  intervensi kesehatan masyarakat seperti HIV 
tanpa menghambat penyediaan pelayanan? Implementasi untuk Program HIV  yang selama ini disubsidi Pemerintah 
memerlukan kehati-hatian. Studi ini bertujuan untuk menganalisis skenario terkait biaya dan utilisasi pada pelayanan 
HIV guna mendukung kebijakan yang potensial untuk mengintegrasikan intervensi HIV ke dalam paket manfaat JKN. 
Metode: Penelitian ini menganalisis paket manfaat dan mekanisme pembiayaan terkait pelayanan HIV, keanggotaan 
JKN, target populasi kunci, serta estimasi premi untuk pelayanan HIV hingga tahun 2019. Studi observasional ini 
menghasilkan data biaya dan utilisasi dari tingkat nasional dan daerah sebagai data dasar.  Peneliti membangun model 
dan menganalisis skenario proyeksi biaya dan utilisasi dari beragam program aktivitas HIV  serta konsekuensinya. 
Hasil: Skenario dikembangkan berdasarkan kelengkapan paket manfaat dan komponen mana yang bisa dijamin 
dalam JKN.Pelayanan yang terkait HIV saat ini sebagian besar dijamin oleh pemerintah mulai dari Konseling dan 
Tes HIV Sukarela (KTS) hingga pengobatan Infeksi Oportunistik. Pengobatan dan perawatan kemungkinan dapat 
dijamin oleh JKN, dengan bantuan pemerintah untuk pencegahan dan pelayanan ART. 
Kesimpulan: Skenario  dengan paket manfaat dasar akan membutuhkan  biaya medis yang rasional  per pasien per 
bulan, tergantung pada kelengkapan paket manfaat. Sebuah peta jalan yang jelas perlu disusun t untuk memastikan 
seluruh pelayanan terjangkau dan berkualitas baik.  (Health Science Journal of Indonesia 2019;10(1):67-76)
Kata Kunci: Jaminan kesehatan semesta, pelayanan HIV, dan Opsi Kebijakan
Abstract
Background: HIV and AIDS program in Indonesia is planned to be financed by domestic sources after depending 
on external sources for many years. Indonesia has started its Social Health Insurance scheme so called Jaminan 
Kesehatan Nasional (JKN) program in 2014, that covers  HIV treatment including opportunistic infection.  Research 
question is whether JKN could expand its benefit package to public health interventions without hampering service 
provision. Converting  HIV program that has been subsidizied by the Government needs careful considerations. The 
study aimed to assess  scenarios on cost and utilization to support decision on  integration of HIV interventions into 
the JKN benefit package.  
Methods: The study assessed the current coverage and funding mechanisms for HIV-related services, JKN 
membership,  key target populations, and estimated premium for HIV services up to 2019.  We captured cost and 
utilization  from national and subnational levels as the baseline through an observational study. Researchers developed 
model and  scenarios on the projection of cost and utilization of various HIV  program activities and its consequences. 
Results: We developed scnearios based on  benefit covered by JKN. current  services mostly covered by government. 
The Care and treatment could be possibly covered by the JKN, with support from government for prevention and ART. 
Conclusion: The scenarios show that provision of HIV services within the basic benefits package of JKN would 
require a reasonable  cost  per member per month, depending on the comprehensiveness of the benefit. A clear 
roadmap should be developed to ensure all services provided are affordable and in good quality. (Health Science 
Journal of Indonesia 2019;10(1):67-76)
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Indonesia has significant number of people living 
with HIV (PLHIV). The Ministry of Health (MoH) 
1 reported the number of new HIV cases in 2014 
was  32,711 or increased 12.6% compared with 
2013’s cases; while the new AIDS cases was 5,494, 
relievely decrease about 45.9% from the previous 
year.  The National Strategy and Plan mentioned that 
this country confronts two very distinct epidemics 
namely a concentrated epidemic among injecting 
drug users, sex workers, and men-having-sex-with-
men outside of Papua, and a low-level generalized 
epidemic, with transmission among both vulnerable 
groups and the general population in the provinces 
of Tanah Papua2. From financing point of view, the 
annual spending for HIV response in Indonesia has 
increased from USD25 million in 2003 to USD60 
million in 2009 to USD87 million in 2012. The trend 
in 2013 and 2014 also showed increasing spending 
from USD98 million in 2013 to USD107 million in 
2014 3-4. In 2006, public funds were contributed only 
25% of national spending but the trend is increasing 
annually up to 40% in 2012 while funding support 
from the international donor showed a decreasing 
trend. The latest data on spending for HIV response 
in the country showed that government contribution 
has increased to 52% in 2013 and 57% in 2014 4. 
Indonesia should participate and set the target 
of “ending the AIDS epidemic” by 2030 with 
three possible sub-targets related to a) reducing 
new adult HIV infections and eliminating new 
infections among children; b) reducing stigma and 
discrimination faced by people living with HIV 
and key populations; and c) reducing AIDS-related 
deaths2. The World Health Organization (WHO) 
stated that HIV program have opportunities to be 
integrated with other priority health areas, in addition 
to their core business of HIV prevention, diagnosis, 
treatment and care, and its distinct integration with 
maternal and child health and tuberculosis 5. Lesson 
learned from othercountries shows that Universal 
Health Coverage (UHC) conceptis effectively 
ensure that all individual have access to use the 
promotive, curative, rehabilitative and palliative 
healthcare services they need, of sufficient quality to 
be effective, without suffering financial hardship5-9.
Indonesia has already developed its Social Health 
Insurance (SHI) scheme called “Jaminan Kesehatan 
Nasional or JKN” since 2014 with short term goal 
to achieve  Universal health Coverage (UHC) in 
2019 9. Benefit package of the JKN include mainly 
treatment for sick people who has membership of 
the scheme. Typically a public health program such 
as HIV intervention received high subsidy from 
central government. Drugs, medical equipment, 
technical assistance are among support from central 
government, as well as other support that come from 
the Global Fund under MOH’s coordination. Local 
government provides support for operational and 
maintenance of the program to its people, while 
the JKN scheme covers few components such as 
incentive for healthcare facility staffs. Currently, 
initiative to improve effectiveness and eficiency of 
the service provision has been started by identifying 
potential integration of financing and provision of 
services, including for priority programs that have 
been funded by government and JKN. Substantial 
increased of HIV AIDS cases, limited domestic 
resources as well as the need to improve efficiency 
by integrating sources of fund has lead the need to 
conduct this study. The policy question on financing 
part is whether it is possible to inlcude care provision 
and outlay a vertical program such as HIV and listed 
as benefit package of the JKN?  At least four aspects 
need to be considered a) coverage of both targeted 
population and services; b) basic benefit package and 
the cost calculation; c) the payment methods, and d) 
the performance measurement.  This paper  discuss 
the Indonesian context of the potential integration of 
HIV program into the JKN scheme, with particular 
emphasize on cost implication and utilization of 
services.
This study drew policy options for possible 
integration of HIV and AIDS intervention into JKN. 
The objectives of the study  were 1. to develop a 
model based on  list of HIV services to be provided 
and options of the scenarios in the model 2. to 
calculate costs and its trend based on increased need 
and demand for HIV services for each option, and 
3. to provide recommendation on proposed benefit 
package option of HIV intervention including per 
member per month additional premium for its 
inclusion into the JKN scheme and what would be 
the role of the Ministry of Health (MOH). 
METHODS 
We developed a simulation model to analyze 
options of integrating HIV program components 
into benefit package under JKN scheme. The model 
was derived based on evidence from national level 
and selected samples from four provinces. Sampling 
frame was drawn purposively based on coverage 
and substantial contribution from local government 
(based on National AIDS Spending Assessment 
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data, 2015).  Three public hospitals from Bali, West 
Java and Batam as well as two private hospitals 
from Batam and West Java,were selected to capture 
program and costs from hospital perspective. In 
addition, to capture primary care perspective we also 
collected data from eight primary health centers and 
two clinics in West Java and Jakarta. Data collection 
was done for  during November-December 2014. 
Secondary data were analyzed to project coverage and 
resources used (costs). Future costs were projected 
based on the estimated epidemic trajectories until 
the next five years using 2014 data as the baseline. 
Cost analysis was done to capture baseline costs of 
current program coverage and cost of additional HIV 
services inclusion into the existing benefit package. 
The analysis was done during January-March 2015, 
followed by serial discussion with stakeholders to 
verify and confirm the model.
Analysis on the prevention category included 
Sexual Transmission Infection (STI) services, HIV 
Counseling and Testing, Harm Reduction, and 
Prevention of Mother-to-Child Transmission of 
HIV (PMTCT). Meanwhile, the treatment and care 
services covered elements such as screening test 
namely ARV eligibility, prophylaxis drugs, ARV; 
monitoring test namely CD4 & Viral Load (VL) 
testing, Opportunistic Infection Hospitalization, OI 
Drugs, Condoms, and consultation. Cost for each 
service was determined and analyzed by component, 
and verification of component to be covered by the 
JKN or from Government subsidy was conducted.
The study results were discussed in a workshop 
held by the National AIDS Commission involving 
various stakeholders involving informants officials 
from BPJS and program manager and staffs from 
MOH  as well as selected  hospital and health centers, 
and resulted a final model that derived for  two 
scenarios.  A model to calculate cost of integration 
of HIV services into JKN basic benefit package. 
After reviewing the exisiting benefit package and 
the nature of provision of HIV program intervention, 
several options were set up. Various data sources 
were used for the cost calculation including a 
rapid survey on HIV services unit cost, utilization 
and claims data from the JKN program, and HIV 
epidemic data from MOH.  Estimate of coverage and 
its future trend were derived from analysis using Key 
Affected Population (KAP) and People Living with 
HIV (PLHIV) population data from the Ministry of 
Health. Membership data were estimated from JKN 
in order to estimate the cost per member per month, 
and projection analysis was carried out using the 
Asian Epidemic Model (AEM). Thus, epidemiology 
and economic scenario model were systematically 
analyzed and incorporated in the model to show 
future utilization and cost for each option application. 
We consider that ethics approval was not required 
for this study or “not applicable” because this study 
used secondary data and not included any detailed, 
individual patient information.
RESULTS 
Mobilization of domestic resources has increased 
to sustain HIV program funding after external 
funding support graduation from Indonesia. In 2014 
the Government started the Strategic Use of Anti 
RetroViral (SUFA) program to gradually scale up ART 
to all PLHIV regardless of how advanced their HIV 
infection. 10 It is expected that treating more PLHIV 
will help reducing new infections. At the same time, 
the Government has initiated the Comprehensive 
Continuum of Care (CoC) or Layanan Komprehensif 
Berkesinambungan in several sites, and which will 
be rolled out to more districts. Under the SUFA, 
HIV treatment has been expanded and the country 
has made substantial progress in scaling up ART 
coverage. MOH has developed a roadmap with clear 
strategies and implementation plan for (i) expanding 
HIV diagnostics, (ii) promoting effective enrollment 
and retention in HIV care, and (iii) building on the 
LKB. Current coverage and funding mechanism for 
HIV interventions were available under a mix funding 
scheme. Some of components, typically the treatment 
and care services  are already paid using money 
received by healthcare facility through the JKN 
payment i.e through capitation for health center, while 
some prevention program activities remain reliant on 
donor funding. Detail description of coverage scheme 
of each service can be seen in Annex 1.  
Proposed Basic Benefit Package (BBP)
The proposed options of basic benefit package 
that includes HIV services are developed based on 
three considerations (i) the funding source, (ii) who 
will be managing the fund, and (iii) what service 
components to be included in the BBP.
Option 1 - Comprehensive Coverage
The first BBP model covers all HIV-related services 
including counseling and condoms, screening 
tests (pre-ARV, other basic laboratory tests), ARV 
treatment, STI screening tests and treatment, 
Prevention of Mother to Child Transmission services, 
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HIV (OI) services at ambulatory care and inpatient 
setting. This option excludes outreach activities, 
public/mass social behavior change activities and 
community prevention programs.
This option has two financing scenarios :
• Scenario A: The whole cost of above mentioned 
services is included (actuarially calculated) in the 
premium; and paid by all members. For government-
assisted recipients (i.e. the poor) premium 
contribution will be paid by the Government.
• Scenario B:  The whole cost paid by the Government.
Option 2 – Basic HIV Services Coverage
The following options describe HIV-related services 
to be included in the JKN benefit package: 
• Option 2 a – Current Basic Benefit Package 
coverage plus ARV treatment and screening 
tests.
• Option 2 b – Similar to option 2a but exclude 
ARV treatment. ARV remains provided through 
Government vertical channeling mechanism. 
This option has a slight expansion of the 
existing  package.
Financing scheme for this option will be from 
premium contributions and government subsidy 
for ARV. Other  HIV-related services will continue 
to be financed by public (domestic) and external 
financing that is under the ongoing service provision 
mechanism.
This option is a potential start for an incremental 
BBP expansion; over time BBP can be expanded to 
include more services.
Cost of HIV-related services  
As the baseline data for analysis, data on cost from selected 
providers were analyzed by component to describe how 
much cost is actually needed to provide certain benefit 
package. The baseline data is shown in Table 1.
Utilization Rate of HIV Services in BBP
The study used the Asian Epidemic Model (AEM) 
to estimate Key Affected Population (KAP) and 
PLHIV population. The model estimates 8.5 million 
KAP in 2014 and will be increased to 9.1 million 
KAP in 2019. Meanwhile, the number of PLHIV 
was estimated 272,000 people in 2014 and will be 
increased to 331,000  people in 2019 (see Annex. 2). 
Table 1. Unit Cost of HIV Services
Components Benefit Packages Unit Cost (Rp)
Counseling Pre-Counseling 28,834
 Post-Counseling              48,944 
HIV Test Screening test 64,336
 Confirmation test 67,719
STI Lab Test Vaginal Discharge 45,712
 Urethral Discharge 45,712
 Genital Ulcers 39,466
 Pelvic Inflammatory 
disease 
45,712
 Inguinal Bubo 45,712
 Genital vegetation / 
genital warts 
191,500
 Scrotum swelling 45,712
STI Treatment Drugs 140,922
Pre-ARV Test Rontgen 16,679




 Urine Test 46,000
 Viral Load 1,064,125
 HbsAg 136,000
 Sputum 18,937
ARV ARV 1st Line 379,260
 ARV 2nd Line 1,389,981
Side Effect 
Treatment 







Inpatient (Severity I) 3,689,640
 Inpatient (Severity II) 5,693,836
 Inpatient (Severity III) 9,265,506
 Outpatient 278,178
Cost Projection and Per Member Per Month 
(PMPM) Cost Estimate
All costs for HIV services which was calculated 
then multiplied with the number of KAP and this 
generates the total cost estimate for HIV and AIDS 
services. Based on this estimate, the cost per member 
per month is defined.  The 2014 per member per 
month data for the option 2 as the baseline showed 
that with additional HIV comprehensive services the 
additional charge per member was approximately 
IDR466,6 per month or IDR5.599,2 per year 
(approximately equivalent to USD 0.5 where USD 
1 is equivalent with IDR 10,271.64) as seen in the 
Table 2. Meanwhile, PMPM premium of benefit 
package of option 1 can be seen in Annex 3. The 
cost was estimated to cover  comprehensive service 
including counseling, HIV testing, STI laboratory 
test, STI treatment, diagnostic test for pre-ARV, 
ARV treatment, side effect treatment, and PMTCT.
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Table 2. Summary of the PMPM  Cost in 2014
The cost projection between 2015 – 2019 was using 
inflation rate at 4% and trend of utilization rate 
was generated after several consultation meetings 
with HIV-UHC Working Group. The meeting with 
the working group was aimed to identify factors 
influencing the use of services after implementation 
of the national strategic responses, such as expansion 
of ARV (SUFA) and comprehensive continuum of 
care (LKB).
The projection  illustrates high cost to be covered by 
the JKN  in the next 5 years and potentially will be 
doubled in 2019, option 1 projection can be seen in 
Annex 4. The analysis shows an increasing trend not 
only because of thecosts and increasing utilization, 
but also increasing number of people joining the 
JKN. As it was claim in 2014 claims, when UHC had 
just started, people accessing the healthcare facility 
were double compared to 2012. Future trend shows 
that premium (IDR730-1,000 PMPM, depending 
on chosen scenario) in 2019 will be 2 times higher 
than in 2014. This higher rate gives idea to the 
government to expand VCT service which also cover 
condom provision. Overall premium PMPM in 2019 
will be higher in comparison with 2014 premium. 
The premium will be 3 times higher if condom 
and counseling service are included in the benefit 
package and will be 4 times higher if screening for 
HIV test is included in the benefit package. Other 
components demonstrate mild effect indicating a 
slight increased over the years.
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Table 3. Summary of PMPM Cost, 2015-2019 (IDR)
Option Scenario/Model 2014 2015 2016 2017 2018 2019











































The subsidy for HIV and AIDS program was mostly 
for providing ARV and implementing prevention 
program. However, financing for other program 
components remain depend on external support. In 
the past, spending for HIV response in Indonesia is 
dominated by three donors – the GFATM, AusAID, 
and USAID – that together accounted for more than 
90% of total international spending in 2011/12 or 
58% of total HIV expenditures of US$50.2 million. 
In 2012, the Global Fund alone funded 28.6% of 
total national HIV response (or ~ 0.4% of public 
expenditure on health) in the country. Indonesia 
will no longer obtain funding support from the 
Global Fund by 2020 3. The national HIV program 
achievement which substantially influenced by the 
work of NGOs and other stakeholders’ need to be 
sustained. In fact, increasing funding support from 
domestic sources is needed, both from public and 
private sources. From public funding point of view, it 
is expected that role of central and local government 
shall be improved, as well as other potential sources 
for JKN scheme. This study revealed certain option 
for the JKN scheme to support its inclusion of HIV–
related services with careful considerations. 
The current situation on provider payment for 
community health center as primary healthcare 
provider revealed that capitation payment is one 
the main source of fund to support public health 
interventions. However, depending solely on the 
JKN to support such a vertical or integrated program 
remain a challenge. Giving a more flexibility to the 
health center to manage its fund will aid the program 
to strategically use its multiple sources of fund in 
implementing planned activities.
The option 2 was proposed with some reasons. 
Integration of HIV-related services into JKN, requires 
some efforts and considerations. First, continuum of 
care of HIV intervention includes prevention, care 
and treatment also  all others  should be covered. 
Procurement and accountability become a challenge 
the JKN payer. Second, one important issue is  financial 
burden for HIVAIDS in the future can only avoided 
with a good prevention program, hence the outreach 
program should  be continued to ensure prevention 
such as condom use and STDs lab and treatment are 
successfully achieved, which clearly have been funded 
and managed under Government’s source of fund. 
Nevertheless, dealing with stigma around people, 
health workers in facilities in particular should be 
carefully managed. Third, the capacity and quality of 
health provision should be upgraded in many settings 
10. The next important one is a strict and transparent 
monitoring mechanism to ensure professionalism of 
the implementation  (particularly for treatment care) 
and the Ministry of Health (particularly for prevention 
care) to avoid fragmentation of interventions. 
Besides, universal coverage context proponents 
should reforms partnership between government and 
the public communities as the effort of strengthening 
community systems to extend services to marginalized 
and stigmatized populations10.
In addition, vertical program integration to also 
include HIV and AIDS issues into social health 
insurance will impact not only to more services that 
should be covered, but also to consider all matters 
related to health system pillars in all levels. In the 
aspect of human resources among others are (i) 
increasing work-load of health facility workforce, (ii) 
preparing the supportive and complementary services 
for HIV patients, (iii) adding more activities to control 
the treatment cascade for specific target population 
groups, (iv) ensuring that services or benefit packages 
are equal in every region, and (v) other region-based 
problems, such as fragmented services that discourage 
patients in getting certain services, for example, 
diagnostic tests in primary health care while ARV 
services in many regions only exist in hospital11-13.
The researchers acknowledged study limitation that 
mostly because of limited number of samples and 
rapid changing of policy during the implementation 
in the country. The sample selection was not 
intended to represent Indonesia. The difference 
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between local government capacity was not ideally 
captured. However, as a vertical program, role of 
central government is critical and  this situation was 
captured for the model developed. The scenarios 
and projection of the cost, utilization, and cost per 
member per month could be seen as input for further 
steps for strategic purchasing, by carefully looking at 
the need and demand in the future and stakeholders’ 
acceptance. This challenge to integrate this program 
into JKN need further careful assessment, especially 
considering the trend of raising claims for treatment. 
Experience from other countries showed that HIV 
services could possibly be managed by insurance, 
such as in Thailand and Vietnam14-17. Under tax-
based system, insurer/payer could play a central 
role for managing payment and ensuring access for 
PLHIV, such as Thailand where National Health 
Security Office (NHSO) is the payer for national 
HIV program intervention and responsible for 
procurement and monitoring14-15. In other developing 
countries such as in Zimbabwe, increased funding 
from other options was suggested, such as increased 
‘‘sin taxes’’that could decrease HIV related risk 
behaviours18. It was also proposed to seek potential 
support from social health insurance that could help 
attract further household resources18. 
This study revealed that the Basic Package would be 
possibly implemented, where all program components 
that included in the current package/subsidy remain 
available. If it is accepted, the  government would 
remain support ART service. In the context of 
Indonesia, early detection is considered as part of 
government’s role, where VCT services may best be 
scaled up in community-based clinics 19. The increasing 
number of new HIV cases requires increasing demand 
for ART for adults and children with HIV. In 2009, 
a million extra people received ART, but 5.5 million 
of 9.5 million people in need of treatment worldwide 
did not receive ART 17. Furthermore, because the 
WHO guideline recommend earlier initiation of 
ART, the number of people classified as in need of 
treatment will increase by almost half 21-22. Financial 
constraints were reported to be the most significant 
barrier to antiretroviral adherence in patients living 
with HIV and AIDS in Botswana and other countries 
in sub-saharan Africa prior to the introduction of free 
treatment21-23.
In the case of Indonesia, to ensure ART is provided 
timely at reasonable price is part of the underlying 
consideration why option 2 is more favorable. In 
addition, prophylaxis and side effect treatment 
should be included in option of basic package. Under 
most reasonable option, the government should seek 
more fund to support the program.
In conclusion, 1. Although burden of current HIV 
and AIDS services claims under the SHI scheme 
is only 1% compared to total claims, without a 
systematic case prevention the government will 
be facing potential increase of financial burden to 
cover treatment in the future. This means the JKN 
should also take part in prevention. However, this 
does not mean all tasks will be shifted to JKN. 
Some of the services are potentially managed under 
UHC and program that related to public health and 
outreach programs should remain as government 
responsibility.  
2. Some HIV services integration into the JKN would 
help improve provision of treatment and care more 
efficient while it can be done at affordable  cost. 
Choosing option 2 or Basic Benefit Package will 
increase the premium up to only 2% while Option 1 
will increase 3% of the premium.  
3. A clear and realistic roadmap for integration of 
HIV services into the JKN should be developed if it 
is to be done in an incremental manner in changing 
the funding mechanism. In addition, monitoring 
and evaluation plan development and other efforts 
should be taken into consideration such as handling 
the sensitive issues due to social stigmatization of 
PLHIV and targeted population.
4. The integration of HIV services into the JKN should 
be considered as a part of the efforts to develop the 
country’s transition plan from donor dependency to 
ensure financial and programmatic sustainability of 
the National HIV response. The Ministry of Health 
is responsible for HIV prevention and care program, 
ARV provision as well as ensuring its availability 
and accessibility for those who need it.
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Annex




Service elements Current Coverage/Funding mechanism
Prevention STI services Diagnostic : STI tests JKN and Public Financing
Drugs JKN and Public Financing
Condom and lubricant Public - Domestic and External
IEC materials Public - Domestic and External
Consultation (Medical and 
Lab Technician fee) 





Public financing - Central & Sub National
Condoms Public - Domestic and External
Consultation (Medical and 
LabTechnician  fee) 
JKN and Public Financing
Harm 
Reduction 
NSP Public - Domestic and External
MMT Public financing
Condoms Public – Domestic and External
Consultation (Medical  and 
Lab Technician  fee) 
Public Financing
PMTCT Diagnostic tests Public financing - Central &Sub National
Condoms Public - Domestic and External
ARV Public - Domestic and External
C-section Public - Domestic and External
IEC materials Public - Domestic and External
Consultation (Medical and  
Lab Technician fee) 





Screening tests: ARV 
eligibility 
Public financing - Central & Sub National
Prophylaxis drugs Public - Domestic and External
ARV Public - Domestic and External
Monitoring tests : CD4 & VL Public - Domestic and External
OI Hospitalization JKN
OI Drugs JKN and Public Financing
Condoms Public - Domestic and External
Consultation (Medical& Lab 
fee) 
JKN and Public Financing
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Annex 3. Summary of the Premium PMPM 2014 for Option 1 (IDR)














   1,41
Total PMPM 558,13
Annex 4. Summary of Cost Projection Option 1, 2015-2019 (IDR)
2014 2015 2016 2017 2018 2019
558 747 850 954 1.079      1.196      
Basic
